Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). CHENGDU, China, Jan. 11, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the… CISION PRNewswireJanuary 11, 2025
Press ReleaseXinhua Silk Road: Winter colors in east China's Longtan park BEIJING, Jan. 11, 2025 /PRNewswire/ — Winter has its own full and… CISION PRNewswireJanuary 11, 2025
Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited HONG KONG, Jan. 11, 2025 /PRNewswire/ — Dunxin Financial Holdings ("DXF" or the… CISION PRNewswireJanuary 11, 2025
Press ReleaseCorn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution IRVINE, Calif., Jan. 11, 2025 /PRNewswire/ — Corn Next, a leader in… CISION PRNewswireJanuary 11, 2025
Boqii Announces ADS Ratio Change SHANGHAI, Jan. 11, 2025 /PRNewswire/ — Boqii Holding Limited ("Boqii" or the… CISION PRNewswireJanuary 11, 2025
UGREEN Unveils Groundbreaking AI NAS with Built-In LLM at CES 2025 LAS VEGAS, Jan. 11, 2025 /PRNewswire/ — UGREEN, a leading innovator in… CISION PRNewswireJanuary 11, 2025
Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a… CISION PRNewswireJanuary 11, 2025
Press ReleaseRingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air LAS VEGAS, Jan. 10, 2025 /PRNewswire/ — RingConn, a leading smart wearable… CISION PRNewswireJanuary 11, 2025
